ESVSEuropean Society for Vascular Surgery
ESVSEscape Suit Ventilation System
ESVSEnhanced and Synthetic Vision System
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
ESVs: Strong growth in operating metrics, revenue and overall portfolio valuation
Ofcom's compliance with ECC decisions regarding ESVs means that Kymeta installations under this authority are granted free circulation in the 48 CEPT member countries.
Left ventricular end-diastolic volume (EDV), end-systolic volume (ESV) and ejection fraction (EF) were calculated from the 16-frame and 8-frame data sets.
Given the significance of tactical mobility to successful attacks, each engineer company is comprised with the ESV. The ESV is designed to neutralize obstacles and mark lanes using their mine-clearing plow, straight blade plow, mine-clearing rollers, and towing a trailer with MICLIC.
General Motors Corporation (NYSE: GM), a United States-based automaker, is recalling 1,402 Cadillac Escalades and Escalade ESVs.
According to the company, the US FDA has approved a combination of changes in the application of the eSVS Mesh to the saphenous vein graft and to the surgical implant technique for the eSVS Mesh treated graft to reduce the risk of early graft occlusion, make it easier to implant the eSVS Mesh and reduce procedural costs.
The Norwegian company will introduce the product at the annual conference of the European Society for Vascular Surgery (ESVS), which is taking place from 22 to 25 September in Athens.
The company said it would use the raised funds for regulatory clearance and marketing of its external saphenous vein support technology, eSVS MESH, in the US, for working capital and general corporate funding.
The most costly aspect of the new legislation is likely the requirement to install Excess Flow Valves (ESVs) on all new and replaced service lines serving single family residences if practical.
'Our T3 i-Series ESVs are ideal for international public safety applications around the world.
In an SEC filing, Kips Bay officials said they hoped to raise $57.5 million from the public offering of stock to seek regulatory approval for the company's eSVS Mesh.
The development-stage company is focused on developing and commercializing a vein-support device called eSVS MESH, a mesh sleeve implanted by surgeons in coronary artery bypass grafting (CABG) that, when placed over a patient's vein graft, improves the graft's structure and long-term performance.